Find Your Funding Opportunity
Impact of Initial Influenza Exposure on Immunity in Infants
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
02-11-2026 | $10.0 M | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Expected Number of Awards 3
- Opportunity Type Discretionary
-
CFDA
93.855 -- Allergy and Infectious Diseases Research
Description
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support toestablish, follow, and characterize longitudinal cohorts of infants and/or mother-infant dyads to determine how influenza infections and/or vaccinations shape infant and childhood immunity. These studies will define and characterize immunity acquired upon initial exposure (including in utero) to influenza antigens from natural infections and/or vaccinations and examine how these exposures influence immune responses to subsequent influenza infections and/or vaccines. Projects that include mother-infant dyads will also study the role of maternal influenza immune status on neonatal responses to influenza infection and/or vaccination. The overall goal of this research is to provide key information to facilitate design of durable, broadly protective influenza vaccines.Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Key Date(s)
- July 08, 2025: Last Updated Date
- July 08, 2025: Forecasted Date
- December 12, 2025: Estimated Post Date
- February 11, 2026: Estimated Application Due Date
- December 01, 2026: Estimated Project Start Date
- December 01, 2026: Estimated Award Date